GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a major focus in medical studies, largely due to its impressive impact on controlling ailments such as type 2 diabetes and excess body fat. Ongoing trials have shown that more than glucose control, GLP-1 drugs offer potential for heart health and even cognitive diseases.